Mutagenesis, Insertional: Clinical Trials

4 trials of Mutagenesis, Insertional, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Unknown 2

Follow Mutagenesis, Insertional: new trials by email Literature Review of Mutagenesis, Insertional trials Research Report on Mutagenesis, Insertional

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DEXTENZA for the Treatment of Pain and Inflammation Following Surgical Trabeculectomy and Ahmed Valve Procedures
DEXTENZA, Topical Dexamethasone - Glaucoma Following Surgery
Phase 4UnknownBrian Jerkins, MD302021-11-012021-11-11
Dextenza for Post-operative Treatment of Pterygium
Intracanalicular Dexamethasone, (0.4 mg) Insert, Prednisolone Acetate - Pterygium of Both Eyes
Phase 4CompletedBrandon Eye Associates, PA202020-07-152025-05-25
Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert
Intracanalicular Dexamethasone, 0.4 mg insert - Glaucoma, Primary Open Angle, Cataract
Phase 4CompletedWolstan and Goldberg Eye Associates402020-02-102022-08-22
Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA) in Ureteral Obstruction
cSEMS(Covered self-expandable dual-layered metal stent) implant - Ureteral Obstruction
Phase 4UnknownSamsung Medical Center922012-06-012013-02-11

Conditions studied

Cataract (1)  ·  Glaucoma, Open-Angle (1)  ·  Ureteral Obstruction (1)

Sponsors

Brandon Eye Associates, PA (1)  ·  Brian Jerkins, MD (1)  ·  Samsung Medical Center (1)  ·  Wolstan and Goldberg Eye Associates (1)

Countries

United States (3)  ·  South Korea (1)

Top investigators

Brian Jerkins, MD (1)  ·  Damien Goldberg, MD (1)  ·  Deok Hyun Han, M.D. (1)